Zoltán Kaló and colleagues consider approaches to counter systemic inequities and power imbalances arising from discrete national policies for drug pricing and reimbursement Current pricing mechanisms ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback